Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 4,495.00
+600.00 (15.40%)
At close: Oct 13, 2026
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 91.53 billion as of October 12, 2026. It is the 28,829th most valuable company in the world and the 1,438th biggest in South Korea. Its market cap has increased by 2.63% in one year.
Market Cap
91.53B
Enterprise Value
107.20B
Revenue
181.27B
Global Rank
Country Rank
#1,438 South Korea
PE Ratio
16.24
ChartMarket Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 91.53B, an increase of 208.79%. That is a compound annual growth rate of 5.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 91.53B | 4.53% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 142.50B |
| Kyongbo Pharmaceutical | 131.49B |
| SAMSUNG PHARM. Co., LTD. | 129.51B |
| Dong Sung Bio Pharm.Co.,Ltd. | 120.45B |
| Jeil Pharma Holdings | 115.90B |
| HANDOK | 111.72B |
| CMG Pharmaceutical | 83.25B |
| CKD Bio | 76.86B |